Here's how EURJMEDRES.BIOMEDCENTRAL.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

EURJMEDRES . BIOMEDCENTRAL . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Eurjmedres.biomedcentral.com Make Money
  6. How Much Does Eurjmedres.biomedcentral.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. CDN Services

We are analyzing https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-025-02334-8.

Title:
METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4 | European Journal of Medical Research | Full Text
Description:
Ulcerative colitis (UC) is non-specific inflammatory bowel disease. UC development and progression were closely associated with epigenetic modifications. Nevertheless, the specific relationship between N6-methyladenosine (m6A) modification at RNA transcription levels and UC pathogenesis remains unclear. We established UC cell models and mouse models through dextran sulfate sodium (DSS) induction. The expression levels of METTL14 were analyzed via qRT-PCR and western blot. In vitro functional experiments evaluated the effects of METTL14 overexpression on the viability of DSS-induced NCM460 cells and ferroptosis markers. Use of the m6A methylation detection kit, MeRIP-qPCR, and RNA stability experiments confirmed the molecular mechanism controlled by METTL14. In vivo experiments with inflammatory mice models elucidated the interaction between METTL14 and GPX4. Findings from this study indicated a notable reduction in m6A methyltransferase METTL14 expression in DSS-induced NCM460 cells and DSS-induced mice models. METTL14 overexpression effectively suppressed ferroptosis in DSS-induced NCM460 cells. In addition, METTL14 enhanced GPX4 mRNA stability through mediating m6A modification, and the interplay between METTL14 and GPX4 through m6A modification introduced innovative therapeutic approaches for UC management.
Website Age:
25 years and 10 months (reg. 1999-08-06).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is eurjmedres.biomedcentral.com built with?

Custom-built

No common CMS systems were detected on Eurjmedres.biomedcentral.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of eurjmedres.biomedcentral.com audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 55,237 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Eurjmedres.biomedcentral.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (3)
yourbow.com, google.com, doceree.com

How Much Does Eurjmedres.biomedcentral.com Make? {💰}


Display Ads {🎯}

$760 per month
According to our algorithms, Eurjmedres.biomedcentral.com's monthly online income from display advertising ranges from $506 to $1,391.

Keywords {🔍}

mettl, cells, pubmed, gpx, cell, article, google, scholar, ferroptosis, ncm, mice, dss, expression, colitis, levels, cas, fig, modification, mrna, inflammatory, group, rna, intestinal, central, iron, gsh, dssinduced, oemettl, groups, progression, colon, treatment, mda, overexpression, study, model, research, stability, disease, experiments, dai, ros, score, chen, ulcerative, cancer, inflammation, subsequently, protein, assessed,

Topics {✒️}

regulating ampk/mtor/p70s6k-mediated autophagy mettl3-mediated pre-mir-34a sds-page gel electrophoresis galectin-3/tlr4/nf-κb pathway exosomal mir-34a-5p residual dcfh-da dye mettl3/alkbh5/ythdf2 regulated dss + oe-mettl14 + sh-gpx4 dss + oe-mettl14 + sh-nc springer nature sh-gpx4 significantly countered copper-dependent autophagic degradation sh-gpx4 partially counteracting mettl14-mediated m6a modification nrf2-gpx4 signaling pathway additional information publisher' ferroptosis-induced cell death dss-treated ncm460 cells dss-induced ncm460 cells m6a methylation-related genes iron death-related markers aforementioned dss-treated cells oe-mettl14 + sh-gpx4 author ying zhou oe-mettl14 + sh-nc ythdf1-traf6 pathway regulates privacy choices/manage cookies sh-gpx4 partly mitigated alleviates experimental colitis dss-induced mice models dextran sulfate sodium alleviate chemotherapy responsiveness n6-methyladenosine modification participates mediated m6a modification inflammatory bowel disease bmc inflammatory cytokines tnf-α intestinal mucosal inflammation induced experimental colitis authors scientific editing dss-induced uc mice intestinal epithelial barrier account european journal epithelial injury score fresh colon tissue references yang normal group received merip-qpcr merip-qpcr mucosal muscular infiltration = 2 dss-induced colitis

Questions {❓}

  • What does disease progression look like in ulcerative colitis, and how might it be prevented?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4
         description:Ulcerative colitis (UC) is non-specific inflammatory bowel disease. UC development and progression were closely associated with epigenetic modifications. Nevertheless, the specific relationship between N6-methyladenosine (m6A) modification at RNA transcription levels and UC pathogenesis remains unclear. We established UC cell models and mouse models through dextran sulfate sodium (DSS) induction. The expression levels of METTL14 were analyzed via qRT-PCR and western blot. In vitro functional experiments evaluated the effects of METTL14 overexpression on the viability of DSS-induced NCM460 cells and ferroptosis markers. Use of the m6A methylation detection kit, MeRIP-qPCR, and RNA stability experiments confirmed the molecular mechanism controlled by METTL14. In vivo experiments with inflammatory mice models elucidated the interaction between METTL14 and GPX4. Findings from this study indicated a notable reduction in m6A methyltransferase METTL14 expression in DSS-induced NCM460 cells and DSS-induced mice models. METTL14 overexpression effectively suppressed ferroptosis in DSS-induced NCM460 cells. In addition, METTL14 enhanced GPX4 mRNA stability through mediating m6A modification, and the interplay between METTL14 and GPX4 through m6A modification introduced innovative therapeutic approaches for UC management.
         datePublished:2025-02-08T00:00:00Z
         dateModified:2025-02-08T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1186/s40001-025-02334-8
         keywords:
            Colitis
            METTL14
            m6A
            GPX4
            Ferroptosis
            Medicine/Public Health
            general
            Infectious Diseases
            Internal Medicine
            Surgery
            Oncology
            Biomedicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig6_HTML.png
         isPartOf:
            name:European Journal of Medical Research
            issn:
               2047-783X
            volumeNumber:30
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yuhua Chen
               affiliation:
                     name:Dongguan Hospital of Traditional Chinese Medicine
                     address:
                        name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Weicong Fan
               affiliation:
                     name:Dongguan Hospital of Traditional Chinese Medicine
                     address:
                        name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ying Lyu
               affiliation:
                     name:Dongguan Hospital of Traditional Chinese Medicine
                     address:
                        name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jingsheng Liao
               affiliation:
                     name:The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital)
                     address:
                        name:Medical Oncology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ying Zhou
               affiliation:
                     name:Dongguan Hospital of Traditional Chinese Medicine
                     address:
                        name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4
      description:Ulcerative colitis (UC) is non-specific inflammatory bowel disease. UC development and progression were closely associated with epigenetic modifications. Nevertheless, the specific relationship between N6-methyladenosine (m6A) modification at RNA transcription levels and UC pathogenesis remains unclear. We established UC cell models and mouse models through dextran sulfate sodium (DSS) induction. The expression levels of METTL14 were analyzed via qRT-PCR and western blot. In vitro functional experiments evaluated the effects of METTL14 overexpression on the viability of DSS-induced NCM460 cells and ferroptosis markers. Use of the m6A methylation detection kit, MeRIP-qPCR, and RNA stability experiments confirmed the molecular mechanism controlled by METTL14. In vivo experiments with inflammatory mice models elucidated the interaction between METTL14 and GPX4. Findings from this study indicated a notable reduction in m6A methyltransferase METTL14 expression in DSS-induced NCM460 cells and DSS-induced mice models. METTL14 overexpression effectively suppressed ferroptosis in DSS-induced NCM460 cells. In addition, METTL14 enhanced GPX4 mRNA stability through mediating m6A modification, and the interplay between METTL14 and GPX4 through m6A modification introduced innovative therapeutic approaches for UC management.
      datePublished:2025-02-08T00:00:00Z
      dateModified:2025-02-08T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1186/s40001-025-02334-8
      keywords:
         Colitis
         METTL14
         m6A
         GPX4
         Ferroptosis
         Medicine/Public Health
         general
         Infectious Diseases
         Internal Medicine
         Surgery
         Oncology
         Biomedicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-025-02334-8/MediaObjects/40001_2025_2334_Fig6_HTML.png
      isPartOf:
         name:European Journal of Medical Research
         issn:
            2047-783X
         volumeNumber:30
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yuhua Chen
            affiliation:
                  name:Dongguan Hospital of Traditional Chinese Medicine
                  address:
                     name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Weicong Fan
            affiliation:
                  name:Dongguan Hospital of Traditional Chinese Medicine
                  address:
                     name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ying Lyu
            affiliation:
                  name:Dongguan Hospital of Traditional Chinese Medicine
                  address:
                     name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jingsheng Liao
            affiliation:
                  name:The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital)
                  address:
                     name:Medical Oncology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ying Zhou
            affiliation:
                  name:Dongguan Hospital of Traditional Chinese Medicine
                  address:
                     name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:European Journal of Medical Research
      issn:
         2047-783X
      volumeNumber:30
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dongguan Hospital of Traditional Chinese Medicine
      address:
         name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
         type:PostalAddress
      name:Dongguan Hospital of Traditional Chinese Medicine
      address:
         name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
         type:PostalAddress
      name:Dongguan Hospital of Traditional Chinese Medicine
      address:
         name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
         type:PostalAddress
      name:The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital)
      address:
         name:Medical Oncology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan, China
         type:PostalAddress
      name:Dongguan Hospital of Traditional Chinese Medicine
      address:
         name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yuhua Chen
      affiliation:
            name:Dongguan Hospital of Traditional Chinese Medicine
            address:
               name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
               type:PostalAddress
            type:Organization
      name:Weicong Fan
      affiliation:
            name:Dongguan Hospital of Traditional Chinese Medicine
            address:
               name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
               type:PostalAddress
            type:Organization
      name:Ying Lyu
      affiliation:
            name:Dongguan Hospital of Traditional Chinese Medicine
            address:
               name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
               type:PostalAddress
            type:Organization
      name:Jingsheng Liao
      affiliation:
            name:The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital)
            address:
               name:Medical Oncology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ying Zhou
      affiliation:
            name:Dongguan Hospital of Traditional Chinese Medicine
            address:
               name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
      name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
      name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
      name:Medical Oncology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan, China
      name:Anorectal Department, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China

External Links {🔗}(183)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js

CDN Services {📦}

  • Crossref

4.01s.